Dr. Reddy's Laboratories (RDY) Short Interest Ratio & Short Volume → Biden Nomination CANCELED? (From The Freeport Society) (Ad) Free RDY Stock Alerts $68.26 -1.04 (-1.50%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Dr. Reddy's Laboratories Short Interest DataCurrent Short Volume867,900 sharesPrevious Short Volume751,000 sharesChange Vs. Previous Month+15.57%Dollar Volume Sold Short$63.76 millionShort Interest Ratio / Days to Cover4.6Last Record DateApril 30, 2024Outstanding Shares166,880,000 sharesPercentage of Shares Shorted0.52%Today's Trading Volume216,784 sharesAverage Trading Volume246,298 sharesToday's Volume Vs. Average88% Short Selling Dr. Reddy's Laboratories ? Sign up to receive the latest short interest report for Dr. Reddy's Laboratories and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatRDY Short Interest Over TimeRDY Days to Cover Over TimeRDY Percentage of Float Shorted Over Time Ad The Freeport SocietyPOTUS in ‘25 Not Biden/Trump, ButAnd I believe when they do take the oath of office, their fingers will be crossed… and America will descend into chaos.Click here now to see my urgent election warning. Dr. Reddy's Laboratories Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2024867,900 shares $63.76 million +15.6%N/A4.6 $73.47 4/15/2024751,000 shares $53.45 million +20.0%N/A3.9 $71.17 3/31/2024625,800 shares $45.90 million -11.8%N/A3.2 $73.35 3/15/2024709,300 shares $53.36 million +9.4%N/A3.5 $75.23 2/29/2024648,100 shares $49.79 million -6.6%N/A2.8 $76.83 2/15/2024693,500 shares $52.03 million -9.7%N/A2.9 $75.02 Get the Latest News and Ratings for RDY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Dr. Reddy's Laboratories and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024768,000 shares $55.35 million +4.3%N/A3.2 $72.08 1/15/2024736,100 shares $51.07 million -13.4%N/A2.9 $69.38 12/31/2023849,500 shares $59.11 million -22.8%N/A3.3 $69.58 12/15/20231,100,000 shares $73.29 million -5.2%N/A4.1 $66.63 11/30/20231,160,000 shares $81.08 million +9.4%N/A4.4 $69.90 11/15/20231,060,000 shares $69.64 million -16.5%N/A4.3 $65.70 10/31/20231,270,000 shares $82.72 million +4.1%N/A4.3 $65.13 10/15/20231,220,000 shares $81.04 million +10.9%N/A4.1 $66.43 9/30/20231,100,000 shares $73.56 million -36.8%N/A3.8 $66.87 9/15/20231,740,000 shares $121.54 million +8.1%N/A6.3 $69.85 8/31/20231,610,000 shares $109.44 million -6.9%N/A6 $67.98 8/15/20231,730,000 shares $122.95 million +32.1%1.0%6.6 $71.07 7/31/20231,310,000 shares $89.97 million -4.4%0.8%5.4 $68.68 7/15/20231,370,000 shares $84.80 million -23.5%0.8%5.9 $61.90 6/30/20231,790,000 shares $112.99 million -4.3%N/A7.5 $63.13 6/15/20231,870,000 shares $111.07 million -1.1%N/A7.6 $59.40 5/31/20231,890,000 shares $104.31 million +3.3%N/A7.6 $55.19 5/15/20231,830,000 shares $101.20 million -3.7%N/A7.6 $55.30 4/30/20231,900,000 shares $114.87 million +7.3%N/A9 $60.46 4/15/20231,770,000 shares $106.36 million No ChangeN/A8.8 $60.09 3/31/20231,770,000 shares $100.77 million +29.2%N/A9.1 $56.93 3/15/20231,370,000 shares $73.13 million +1.5%N/A7.5 $53.38 2/28/20231,350,000 shares $70.54 million +6.3%N/A7.9 $52.25 2/15/20231,270,000 shares $70.09 million +7.6%N/A6.9 $55.19 1/31/20231,180,000 shares $63.48 million -12.6%N/A5.9 $53.80 1/15/20231,350,000 shares $72.36 million +16.4%N/A6.3 $53.60 12/30/20221,160,000 shares $60.03 million No ChangeN/A5.5 $51.75 12/15/20221,160,000 shares $62.08 million -8.7%N/A5.3 $53.52 11/30/20221,270,000 shares $71.51 million -2.3%N/A5.3 $56.31 11/15/20221,300,000 shares $71.54 million -19.8%N/A5.6 $55.03 10/31/20221,620,000 shares $87.98 million +3.9%N/A6.9 $54.31 10/15/20221,560,000 shares $80.71 million -12.9%N/A7.3 $51.74 9/30/20221,790,000 shares $93.69 million +5.9%N/A8 $52.34 9/15/20221,690,000 shares $87.39 million +13.4%N/A8 $51.71The ONE AI Stock to own now. (It’s not Nvidia.) (Ad)Don’t panic — you haven’t missed the boat on AI. In fact, it has barely launched. Sure, the early stages of this boom were big … But I believe the real wealth in AI has yet to be made …Click here to see the presentation now. RDY Short Interest - Frequently Asked Questions What is Dr. Reddy's Laboratories' current short interest? Short interest is the volume of Dr. Reddy's Laboratories shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 867,900 shares of RDY short. Learn More on Dr. Reddy's Laboratories' current short interest. What is a good short interest ratio for Dr. Reddy's Laboratories? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RDY shares currently have a short interest ratio of 5.0. Learn More on Dr. Reddy's Laboratories's short interest ratio. Which institutional investors are shorting Dr. Reddy's Laboratories? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Dr. Reddy's Laboratories: Walleye Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Dr. Reddy's Laboratories' short interest increasing or decreasing? Dr. Reddy's Laboratories saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 867,900 shares, an increase of 15.6% from the previous total of 751,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Dr. Reddy's Laboratories' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Dr. Reddy's Laboratories: United Therapeutics Co. (9.42%), Sarepta Therapeutics, Inc. (6.02%), Catalent, Inc. (3.67%), Viatris Inc. (3.84%), Roivant Sciences Ltd. (8.27%), Elanco Animal Health Incorporated (2.73%), Legend Biotech Co. (7.30%), Viking Therapeutics, Inc. (10.98%), BioMarin Pharmaceutical Inc. (2.06%), BeiGene, Ltd. (1.93%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Dr. Reddy's Laboratories stock? Short selling RDY is an investing strategy that aims to generate trading profit from Dr. Reddy's Laboratories as its price is falling. RDY shares are trading down $1.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Dr. Reddy's Laboratories? A short squeeze for Dr. Reddy's Laboratories occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of RDY, which in turn drives the price of the stock up even further. How often is Dr. Reddy's Laboratories' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RDY, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: United Therapeutics Short Interest Sarepta Therapeutics Short Interest Catalent Short Interest Viatris Short Interest Roivant Sciences Short Interest Elanco Animal Health Short Interest Legend Biotech Short Interest Viking Therapeutics Short Interest BioMarin Pharmaceutical Short Interest BeiGene Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:RDY) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsBuy this small stock before coming AI Tidal WaveChaikin AnalyticsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingShocking $16T Elon Musk Crypto LeakCrypto 101 MediaHow Biden has already won 2024Porter & CompanyExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersUrgent Nvidia WarningAltimetry41 banks launch ‘crypto dollar’Stansberry Research